Author

Michael B. Gill

University of CambridgePrimary ORCID profile (0000-0001-6798-1550 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Michael B. GilliD1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Clive S. D’SantosiD· 1 shared Danish MemoniD· 1 shared David OchoaiD· 1 shared Eva Papachristou· 1 shared Martin L. MilleriD· 1 shared Pedro BeltrãoiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Clive S. D’SantosORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Copy number aberrations drive kinase re-wiring leading to genetic vulnerabilities in cancer

Danish Memon, Michael B. Gill, Eva Papachristou, David Ochoa, Clive S. D’Santos, Martin L. Miller, Pedro Beltrão

The paper identifies copy number aberrations that alter kinase signaling and highlights potential therapeutic targets by integrating genomic and proteomic data across cancer samples.

bioRxiv · Jan 9, 2019 · PreprintGenomics